These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33976000)

  • 1. Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report.
    Alanli R; Kucukay MB; Ozdemir O
    Indian J Pharmacol; 2021; 53(1):60-62. PubMed ID: 33976000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine treats intravenous amiodarone induced liver injury.
    Mudalel ML; Dave KP; Hummel JP; Solga SF
    World J Gastroenterol; 2015 Mar; 21(9):2816-9. PubMed ID: 25759554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute liver failure with amiodarone infusion: A case report and systematic review.
    Jaiswal P; Attar BM; Yap JE; Devani K; Jaiswal R; Wang Y; Szynkarek R; Patel D; Demetria M
    J Clin Pharm Ther; 2018 Feb; 43(1):129-133. PubMed ID: 28714083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators.
    Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications and acute hepatotoxicity of intravenous amiodarone.
    Huang X; Yang Y; Zhu J; Gao X; Wang G; Tan H; Liang Y; Li J
    J Int Med Res; 2009; 37(6):1928-36. PubMed ID: 20146893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatitis caused by intravenous amiodarone].
    Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
    Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hepatitis complicating intravenous amiodarone treatment.
    Agozzino F; Picca M; Pelosi G
    Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid acute amiodarone-induced hepatotoxicity in a burn patient.
    Maker AV; Orgill DP
    J Burn Care Rehabil; 2005; 26(4):341-3. PubMed ID: 16006841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
    Hsieh YC; Huang JL; Chin CS; Lin TC; Liao YC; Ting CT; Wu TJ
    Europace; 2011 Jan; 13(1):137-9. PubMed ID: 20851824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
    Satomi K; Kurita T; Takatsuki S; Yokoyama Y; Chinushi M; Tsuboi N; Nitta T; Shoda M; Mitamura H
    Circ J; 2006 Aug; 70(8):977-84. PubMed ID: 16864928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing amiodarone: an evidence-based review of clinical indications.
    Vassallo P; Trohman RG
    JAMA; 2007 Sep; 298(11):1312-22. PubMed ID: 17878423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal amiodarone-induced hepatotoxicity: a case report and literature review.
    Chan AL; Hsieh HJ; Hsieh YA; Lin SJ
    Int J Clin Pharmacol Ther; 2008 Feb; 46(2):96-101. PubMed ID: 18218290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatic failure following intravenous amiodarone.
    Grecian R; Ainslie M
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23257638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
    López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
    Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.